Literature DB >> 14978347

ATP- and adenosine-mediated signaling in the central nervous system: chronic pain and microglia: involvement of the ATP receptor P2X4.

Kazuhide Inoue1, Makoto Tsuda, Schuichi Koizumi.   

Abstract

We have been studying the role of ATP receptors in pain and already reported that activation of P2X(2/3) heteromeric channel/receptor in primary sensory neurons causes acutely tactile allodynia, one hallmark of neuropathic pain. We report here that tactile allodynia under the chronic pain state requires an activation of the P2X(4) ionotropic ATP receptor and p38 mitogen-activated protein kinase (MAPK) in spinal cord microglia. Two weeks after L5 spinal nerve injury, rats displayed a marked mechanical allodynia. In the rats, activated microglia were detected in the injured side of the dorsal horn and the level of the dually-phosphorylated active form of p38MAPK (phospho-p38MAPK) in these microglia was increased. Moreover, intraspinal administration of a p38MAPK inhibitor, SB203580, suppressed the allodynia. We also found that the expression level of P2X(4) was increased strikingly in spinal cord microgila after nerve injury and that pharmacological blockade or inhibition of the expression of P2X(4) reversed the allodynia. Taken together, our results demonstrate that activation of P2X(4) or p38MAPK in spinal cord microglia is necessary for tactile allodynia after nerve injury.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14978347     DOI: 10.1254/jphs.94.112

Source DB:  PubMed          Journal:  J Pharmacol Sci        ISSN: 1347-8613            Impact factor:   3.337


  19 in total

1.  Purinergic receptors activating rapid intracellular Ca increases in microglia.

Authors:  Alan R Light; Ying Wu; Ronald W Hughen; Peter B Guthrie
Journal:  Neuron Glia Biol       Date:  2006-05

Review 2.  Pharmacology of P2X channels.

Authors:  Joel R Gever; Debra A Cockayne; Michael P Dillon; Geoffrey Burnstock; Anthony P D W Ford
Journal:  Pflugers Arch       Date:  2006-04-29       Impact factor: 3.657

3.  Minocycline prevents impaired glial glutamate uptake in the spinal sensory synapses of neuropathic rats.

Authors:  H Nie; H Zhang; H R Weng
Journal:  Neuroscience       Date:  2010-08-03       Impact factor: 3.590

4.  Brain activity for spontaneous pain of postherpetic neuralgia and its modulation by lidocaine patch therapy.

Authors:  P Y Geha; M N Baliki; D R Chialvo; R N Harden; J A Paice; A V Apkarian
Journal:  Pain       Date:  2006-10-25       Impact factor: 6.961

5.  Regulation of the desensitization and ion selectivity of ATP-gated P2X2 channels by phosphoinositides.

Authors:  Yuichiro Fujiwara; Yoshihiro Kubo
Journal:  J Physiol       Date:  2006-07-20       Impact factor: 5.182

Review 6.  Discovery of P2X7 receptor-selective antagonists offers new insights into P2X7 receptor function and indicates a role in chronic pain states.

Authors:  D L Donnelly-Roberts; M F Jarvis
Journal:  Br J Pharmacol       Date:  2007-04-30       Impact factor: 8.739

Review 7.  TNF-alpha and neuropathic pain--a review.

Authors:  Lawrence Leung; Catherine M Cahill
Journal:  J Neuroinflammation       Date:  2010-04-16       Impact factor: 8.322

8.  Self-regulation of inflammatory cell trafficking in mice by the leukocyte surface apyrase CD39.

Authors:  Matthew C Hyman; Danica Petrovic-Djergovic; Scott H Visovatti; Hui Liao; Sunitha Yanamadala; Diane Bouïs; Enming J Su; Daniel A Lawrence; M Johan Broekman; Aaron J Marcus; David J Pinsky
Journal:  J Clin Invest       Date:  2009-04-20       Impact factor: 14.808

9.  Lidocaine injection into the rat dorsal root ganglion causes neuroinflammation.

Authors:  Livia Puljak; Sanja Lovric Kojundzic; Quinn H Hogan; Damir Sapunar
Journal:  Anesth Analg       Date:  2009-03       Impact factor: 5.108

10.  Phosphoinositides regulate P2X4 ATP-gated channels through direct interactions.

Authors:  Louis-Philippe Bernier; Ariel R Ase; Stéphanie Chevallier; Dominique Blais; Qi Zhao; Eric Boué-Grabot; Diomedes Logothetis; Philippe Séguéla
Journal:  J Neurosci       Date:  2008-11-26       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.